PIK3CA and neoplasm: These data suggest that tumour cells in PI3K/mTORi‐ and most prominently PI3K/mTORi+PD‐1i‐treated tumours upregulate antigen processing and presentation in response to IFNγ produced by the enriched tumour‐infiltrating T‐cell population, which in turn makes them more prone to T‐cell attack.